Medicated Skin Care in the United Arab Emirates
OTC medicated skin care suffered due to stronger competition from Rx medicines in 2011. As the country’s economic situation improved and consumers’ economic confidence rose, many traded up from OTC products to Rx alternatives. These products are widely available under-the-counter from chemists/pharmacies and, while more expensive, are generally regarded as more effective. This trend particularly impacted antiparasitics/lice (head and body) treatments, antipruritics, cold sore treatments and...
Euromonitor International's Medicated Skin Care in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Medicated Skin Care in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Medicated Skin Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
Table 3 Medicated Skin Care Company Shares by Value 2007-2011
Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Arab Pharmaceutical Manufacturing Co in Consumer Health (united Arab Emirates)
Strategic Direction
Key Facts
Summary 1 Arab Pharmaceutical Manufacturing Co: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Arab Pharmaceutical Manufacturing Co: Competitive Position 2011
Julphar Gulf Pharmaceuticals in Consumer Health (united Arab Emirates)
Strategic Direction
Key Facts
Summary 3 Julphar Gulf Pharmaceuticals: Key Facts
Summary 4 Julphar Gulf Pharmaceuticals: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Julphar Gulf Pharmaceuticals: Competitive Position 2011
Executive Summary
Review Period Sees Fluctuating Performance
Economic Growth Slows Sales Growth for Consumer Health
Multinationals Lead Fragmented Sales
Chemists/pharmacies Continue To Dominate But Lose Share
Stronger Growth Ahead for Forecast Period
Key Trends and Developments
OTC Faces Strong Competition From Under-the-counter Rx Sales
Rising Disposable Income Levels Encourage Spending
High Levels of Obesity and Overweight Increasingly Trouble Consumers
Focus on Cost Reduction Likely To Boost Domestic Players
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 9 Life Expectancy at Birth 2006-2011
Market Data
Table 10 Sales of Consumer Health by Category: Value 2006-2011
Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 12 Consumer Health Company Shares 2007-2011
Table 13 Consumer Health Brand Shares 2008-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Herbal/traditional Products Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 6 Research Sources
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
Table 3 Medicated Skin Care Company Shares by Value 2007-2011
Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Arab Pharmaceutical Manufacturing Co in Consumer Health (united Arab Emirates)
Strategic Direction
Key Facts
Summary 1 Arab Pharmaceutical Manufacturing Co: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Arab Pharmaceutical Manufacturing Co: Competitive Position 2011
Julphar Gulf Pharmaceuticals in Consumer Health (united Arab Emirates)
Strategic Direction
Key Facts
Summary 3 Julphar Gulf Pharmaceuticals: Key Facts
Summary 4 Julphar Gulf Pharmaceuticals: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Julphar Gulf Pharmaceuticals: Competitive Position 2011
Executive Summary
Review Period Sees Fluctuating Performance
Economic Growth Slows Sales Growth for Consumer Health
Multinationals Lead Fragmented Sales
Chemists/pharmacies Continue To Dominate But Lose Share
Stronger Growth Ahead for Forecast Period
Key Trends and Developments
OTC Faces Strong Competition From Under-the-counter Rx Sales
Rising Disposable Income Levels Encourage Spending
High Levels of Obesity and Overweight Increasingly Trouble Consumers
Focus on Cost Reduction Likely To Boost Domestic Players
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 9 Life Expectancy at Birth 2006-2011
Market Data
Table 10 Sales of Consumer Health by Category: Value 2006-2011
Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 12 Consumer Health Company Shares 2007-2011
Table 13 Consumer Health Brand Shares 2008-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Herbal/traditional Products Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 6 Research Sources
